Protein expression, gene amplification, and mutational analysis of EGFR in triple-negative breast cancer
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Protein expression, gene amplification, and mutational analysis of EGFR in triple-negative breast cancer
Authors
Keywords
Triple-negative breast cancer, EGFR expression, EGFR gene amplification, EGFR gene-activating mutation, Chromosome 7 polysomy
Journal
Breast Cancer
Volume 21, Issue 1, Pages 66-74
Publisher
Springer Nature
Online
2012-04-05
DOI
10.1007/s12282-012-0354-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Triple-negative breast cancer: Histological subtypes and immunohistochemical and clinicopathological features
- (2011) Yuko Ishikawa et al. CANCER SCIENCE
- Hybridization for human epidermal growth factor receptor 2 testing in gastric carcinoma: a comparison of fluorescence in-situ hybridization with a novel fully automated dual-colour silver in-situ hybridization method
- (2011) Elena García-García et al. HISTOPATHOLOGY
- Triple negative breast cancer: unmet medical needs
- (2010) Sumanta Kumar Pal et al. BREAST CANCER RESEARCH AND TREATMENT
- Clinicopathologic and molecular significance of phospho-Akt expression in early invasive breast cancer
- (2010) Mohammed A. Aleskandarany et al. BREAST CANCER RESEARCH AND TREATMENT
- Epidermal growth factor receptor expression in breast cancer association with biologic phenotype and clinical outcomes
- (2010) Mothaffar F. Rimawi et al. CANCER
- EGFR expression and gene copy number in triple-negative breast carcinoma
- (2010) Berrak Gumuskaya et al. CANCER GENETICS AND CYTOGENETICS
- EGFR Fluorescence In situ Hybridization Pattern of Chromosome 7 Disomy Predicts Resistance to Cetuximab in KRAS Wild-type Metastatic Colorectal Cancer Patients
- (2010) Y.-H. Li et al. CLINICAL CANCER RESEARCH
- Triple-negative breast cancer: disease entity or title of convenience?
- (2010) Lisa Carey et al. Nature Reviews Clinical Oncology
- Bright-field In Situ Hybridization for HER2 Gene Amplification in Breast Cancer Using Tissue Microarrays
- (2009) Glenn D. Francis et al. DIAGNOSTIC MOLECULAR PATHOLOGY
- Overview of molecular testing in non-small-cell lung cancer: mutational analysis, gene copy number, protein expression and other biomarkers of EGFR for the prediction of response to tyrosine kinase inhibitors
- (2009) T John et al. ONCOGENE
- Clinicopathological characteristics of triple-negative breast cancers
- (2009) Yuka Sasaki et al. Breast Cancer
- Sensitive detection of EGFR mutations using a competitive probe to suppress background in the SMart Amplification Process
- (2008) Yuki Kawai et al. BIOLOGICALS
- Frequently increased epidermal growth factor receptor (EGFR) copy numbers and decreased BRCA1 mRNA expression in Japanese triple-negative breast cancers
- (2008) Tatsuya Toyama et al. BMC CANCER
- Invasive ductal carcinoma of the breast with the “triple-negative” phenotype: prognostic implications of EGFR immunoreactivity
- (2008) Giuseppe Viale et al. BREAST CANCER RESEARCH AND TREATMENT
- Development of automated brightfield double In Situ hybridization (BDISH) application for HER2 gene and chromosome 17 centromere (CEN 17) for breast carcinomas and an assay performance comparison to manual dual color HER2 fluorescence In Situ hybridization (FISH)
- (2008) Hiroaki Nitta et al. Diagnostic Pathology
- Oestrogen receptor status of breast carcinoma: Allred/H score conversion table
- (2008) S Shousha HISTOPATHOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search